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Abstract
Background: Acupuncture is commonly used to treat chronic sinusitis, though there is little
documentation on the effect. This study presents the health-related quality of life (HRQoL)
outcomes in a trial comparing traditional Chinese acupuncture, sham acupuncture, and
conventional treatment for chronic sinusitis.
Findings: In a three-armed single blind randomized controlled study, we recruited 65 patients with
symptoms of sinusitis >3 months and signs of sinusitis on computed tomography (CT). Patients
were randomized to one of three study arms: (1) 2–4 weeks of medication with antibiotics,
corticosteroids, 0.9% sodium chloride solution, and local decongestants (n = 21), (2) ten
treatments with traditional Chinese acupuncture (n = 25), or (3) ten treatments with minimal
acupuncture at non-acupoints (n = 19). Change in HRQoL was assessed over 12 weeks using the
Chronic Sinusitis Survey (CSS) and Short form 36 (SF-36) questionnaires.
In the study, we found only a non-significant difference on the CSS symptom scale between
conventional medical therapy and traditional Chinese acupuncture. On the SF-36 scale role-physical
the change was larger in the conventional group than in the sham group (p = 0.02), and on the
mental health scale the change in the conventional therapy arm was larger than in the traditional
Chinese acupuncture group (p = 0.03). There was no difference in effect on HRQoL on any scale
between the sham and traditional Chinese acupuncture groups.
Conclusion: There was no clear evidence of the superiority of one treatment over another on
short-term HRQoL outcomes, although there was a statistically non-significant advantage of
conventional therapy in a few dimensions.
Background
Treatment of chronic sinusitis is a well-established proce-
dure in traditional Chinese acupuncture, and acupuncture
is commonly used to relieve sinusitis and nasal symptoms
[1-3]. The symptoms of chronic sinusitis are not easy to
measure or quantify, and health-related quality of life
(HRQoL) has recently gained increasing awareness as an
outcome measure for interventions in chronic sinusitis [4-
6].
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puncture in children and young adults with chronic max-
illary sinusitis, compared with antibiotics and laser
acupuncture [7], and that acupuncture is effective in
sinusitis or sinus pain [8,9]. Recently, we reported only a
nonsignificant advantage of conventional treatment com-
pared with acupucture on symptoms in a three-armed ran-
domized study for CT-verified chronic sinusitis [10]. The
report focused on changes in symptoms, sinus soft tissue
swelling on CT, and the two SF-36 component summary
scales. However, in the study we also included a disease-
specific outcome measure, the Chronic sinusitis survey
(CSS), which was not validated in Norwegian at the time,
but that might be more sensitive to change than the other
HRQoL measures [4].
In the present study, we report the full HRQoL outcomes
from this trial of conventional medical treatment, tradi-
tional Chinese acupuncture and minimal acupuncture at
non-acupoints for CT-verified chronic sinusitis.
Methods
Subjects, study design and interventions
We included patients >17 years of age with sinusitis symp-
toms for >3 months and sinus swelling, fluid retention, or
opacification on CT after screening >500 patients with
sinusitis. We excluded patients if they were pregnant, had
previously had acupuncture treatment, had been operated
on for chronic sinusitis, had polypous sinusitis or pansi-
nusitis, or used medication that could influence the
results of the study. In total, 66 patients were included
between 1996 and 2000. We recruited patients from one
ear-nose-throat practice and advertised the study in local
newspapers and a magazine. One otorhino-laryngologist
examined and included all patients. He allocated them to
one of three groups according to a six-block randomiza-
tion algorithm, by first assigning a patient number to each
patient. He then phoned one of the acupuncturists to
receive information about the group allocation for that
particular patient [10]. The groups were (1) conventional
medical therapy, (2) traditional Chinese acupuncture
(TCA), or (3) minimal acupuncture at non-acupoints
(sham). No patients were included between February and
September to avoid influence from seasonal allergies.
All patients in the conventional medical therapy group
used xylometazoline as local vasoconstrictor, and 0.9%
sodium chloride solution locally for one week, and oral
corticosteroids for 14 days. In addition, 14 patients used
cefalexin 1500 mg daily for 10 days and six used azithro-
mycin 500 mg for 7 days.
Both acupuncture groups had 10 treatments with bilateral
acupoints over 4 weeks, performed by the same experi-
enced acupuncturists with 4–10 years of experience and
with experience in the treatment of chronic sinusitis. The
TCA group patients had individual TCM diagnoses and
treatment using 1.0–1.5 cun needles (Ø 0.28 mm, length
25–40 mm). The needles were inserted to from 0.5 cun
(facial/hand/feet area) to a maximum of 1.3 cun (arms/
legs/trunk area) depth to achieve a good needle sensation,
stimulated manually using reducing or reinforcing meth-
ods and left in the acupoints for 25 minutes [10,11].
In the sham treatment group, the patients were given min-
imal acupuncture at non-acupoints outside the meridians.
One point was situated on each shoulder between LI 15
and TE 14, one on each thigh 3 cun above the midpoint
of the patella, and two bilateral points were situated 2.5
cun lateral to the umbilicus. For the sham group, we used
0.5 cun needles (Ø 0.25 mm, length 13 mm) A shallow,
superficial insertion of the needle (maximum depth 0.25
cun) and minimal needle sensation was emphasized. The
needles were left in the points for 25 minutes[10,12]. We
applied the same sham points during each treatment ses-
sion. In all treatment groups, medication used for other
indications remained unchanged.
Outcome assessment
The participants responded to a questionnaire in the phy-
sician's office at baseline and after 12 weeks, including the
Chronic sinusitis survey and Short Form 36 question-
naires.
Chronic sinusitis survey
The Chronic sinusitis survey (CSS) is a 6-item duration-
based, sinus-specific questionnaire with a symptom and a
medication subscale for use in chronic sinusitis [4,5,13].
Scores were reported on a 0–100 scale, where 100 repre-
sents minimal symtoms or medication use. The Norwe-
gian version of the CSS has only recently been validated
[14].
Short form 36
The Short form 36 (SF-36) assesses eight dimensions of
health status including physical functioning, role limita-
tions due to physical problems, bodily pain, general
health, vitality, social functioning, role limitations due to
emotional problems, and mental health [15,16]. The
scales were scored from 0 (lowest level of functioning) to
100 (highest level of functioning). The SF-36 has been
extensively validated [15,16] and used in subjects with
chronic rhinosinusitis [13,17-19]. We used the Norwe-
gian standard SF-36 version 1.2 [20].
Statistical analysis
Descriptive statistics are presented with means and SDs, or
percentages. We compared changes in HRQoL from base-
line to 12 weeks between groups using one-way analysisPage 2 of 5
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comparisons.
The required sample size was initially estimated to two
groups of 22 patients, to detect a group difference of 0.85
SD on a visual analog scale, with power 0.8 and a 5% con-
fidence level. Before study start, the study protocol was
adjusted to include a third arm with 22 patients [10].
We omitted pairwise comparisons of changes on the CSS
medication effects and total scales involving the conven-
tional treatment group, because medication was part of
the protocol for this group.
We chose a 5% confidence level, using two-sided tests.
The Regional Committee for Medical Research Ethics and
The Norwegian Data Inspectorate approved the study.
Results
The intervention groups were reasonably balanced (Table
1). On baseline sinus CT, three patients in the conven-
tional medicine group had opacification, six in the sham
group, and eight in the TCA group. Only two patients in
the TCA group had baseline fluid retention.
The completion rate at 12 weeks was 17/25 in the TCA
group, 15/19 in the sham group, and 17/21 in the conven-
tional medicine group. Completers, who responded to the
sinusitis symptoms scale of the CSS at baseline and after
12 weeks (n = 47), were somewhat older, had had chronic
sinusitis longer, and had better baseline CSS and SF-36
scores on all subscales than dropouts (n = 18) after 12
weeks, although only the differences on the SF-36 General
health (p = 0.03) and Social functioning scales (p = 0.04)
were statistically significant. From baseline to 12 weeks,
there was a trend to improvement on the CSS sinusitis
symptoms scale in all three allocation groups, but there
was no statistical difference in the changes between
groups (Table 2).
In the conventional treatment group all eight SF-36 scales
improved over the 12-week period (Table 2). Only two
comparisons of the improvements were statistically signif-
icant: conventional medicine vs. sham on the Role-physi-
cal scale and conventional medicine vs. TCA on the
Mental health scale. There was no statistical difference
between TCA and sham on any of the SF-36 scales (Table
2).
Discussion
In this study of patients with CT-verified chronic sinusitis,
there was a small improvement on the CSS sinusitis symp-
tom scale in all three groups over 12 weeks. The improve-
ment was largest for conventional treatment, however
statistically not significantly different from the change in
the two other allocation groups. On the eight SF-36 scales,
there were only significant differences in favor of the con-
ventional group on one scale compared with TCA and on
one scale compared with sham.
The short-term changes in the present report are in line
with our previous report using CT soft tissue swelling,
symptoms and summary scales of the SF-36 as outcomes
[10]. Comparison with other studies is difficult because of
differences in criteria for establishing the diagnosis of
sinusitis, patient selection, lack of feasible control groups,
and use of different outcomes [7]. There was some differ-
ence in the proportion of patients with opacification on
Table 1: Patient baseline characteristics and HRQoL scores according to allocation group, mean (SD)
Acupuncture Sham Conventional
n 23–25 17–19 19–21
Women, number (%) 11 (44) 9 (47) 13 (62)
Age 41 (14) 47 (14) 42 (13)
Duration of chronic sinusitis in years 7 (8) 12 (14) 10 (11)
Chronic sinusitis survey1
Sinusitis symptoms 48 (23) 40 (24) 33 (31)
Medication effects 84 (21) 85 (16) 82 (15)
Total 65 (16) 62 (16) 58 (15)
Short form 362
Physical functioning 77 (25) 85 (15) 86 (15)
Role – physical 48 (41) 61 (40) 54 (41)
Bodily pain 57 (22) 61 (25) 60 (25)
General health 48 (21) 71 (17) 60 (25)
Vitality 42 (24) 51 (21) 49 (23)
Social functioning 67 (27) 72 (23) 69 (28)
Role – emotional 61 (38) 69 (34) 67 (42)
Mental health 75 (16) 78 (11) 69 (21)
1 0 (maximal) to 100 (minimal symptoms/medication use) scale, 2 0 (lowest) to-100 (highest level of functioning) scalePage 3 of 5
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omized study, this distribution was by chance. We have
no reason to believe that this influenced the outcome of
the study. Further, we cannot exclude that some of the
patients may have had symptoms of perennial rhinitis,
though we have no reason to believe that this contributed
to a difference in outcome between the three groups.
A strength of the present study is the randomized design
and the blinding of the patients to the type of acupuncture
given. We used validated instruments for HRQoL assess-
ment; the disease-specific CSS and the well-known SF-36.
The small sample size, and the three intervention groups,
which required adjustment for multiple comparisons,
limited the study power. It is possible that the study was
underpowered, and that the differences in favor of the
conventional treatment group would have been statisti-
cally significant in a larger study.
We used minimal acupuncture at non-acupoints to emu-
late TCA, using a penetrating or invasive sham procedure
on points that were considered inappropriate for treat-
ment of sinusitis. The lack of standardization of treat-
ments may represent a limitation of the study. The TCA
was not standardized, but tailored to the individual
patient according to the traditional Chinese medicine
diagnosis. Similarly, the conventional medical therapy
was not entirely standardized, although all patients had a
common core of local therapy and oral corticosteroids.
Because we included only patients with CT-verified
chronic sinusitis, only 10–15% of the examined patients
were eligible. CT-verified sinusitis is poorly associated
with symptoms [21-23]. Therefore, one should be cau-
tious with generalization beyond patients with CT-veri-
fied sinus soft tissue swelling. In clinical practice the
treatment of sinusitis is initiated without CT scan, and the
diagnosis of chronic sinusitis typically implies having had
sinusitis symptoms for >3 months. Finally, our patients
had longer duration of chronic sinusitis, with mean symp-
tom duration >9 years, and therefore may represent a ther-
apy-resistant population.
Conclusion
We conclude that in this single blind randomized trial,
there was no clear evidence of short-term improvement of
one treatment over another. However, there was a non-
significant advantage of conventional therapy, but this
should be reassessed in a larger trial and with less restric-
tive inclusion criteria. There was no difference in change
in HRQoL between TCA and minimal acupuncture at
non-acupoints.
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Table 2: Change in HRQoL scores from baseline to 12 weeks, mean (SD) unless otherwise stated
Change score Mean difference between change scores
(1) Acupuncture (2) Sham (3) Conventional (1) – (2) (95%CI) p3 (3) – (2) (95%CI) p3 (3) – (1) (95%CI) p3





11 (23) 8 (24) 32 (41) 3 (-24 to 31) 0.96 24 (-3 to 51) 0.09 24 (-3 to 52) 0.14
Medication 
effects
-0.5 (18) 8 (22) -10 (21) -9 (-26 to 9) 0.44 * *




1 (16) 0.5 (13) 6 (17) 1 (-12 to 14) 0.99 5 (-8 to 18) 0.58 5 (-8 to 17) 0.68
Role – 
physical
-3 (48) -12 (39) 28 (36) 9 (-44 to 25) 0.8 40 (5 to 75) 0.02 31 (-3 to 65) 0.08
Bodily pain 2 (23) 5 (23) 16 (20) -3 (-21 to 15) 0.92 11 (-7 to 29) 0.33 14 (-4 to 32) 0.16
General 
health
2 (22) -4 (18) 10 (21) 6 (-11 to 23) 0.67 14 (-3 to 31) 0.13 8 (-9 to 25) 0.48
Vitality -1 (20) 4 (16) 13 (31) -5 (-25 to 14) 0.8 8 (-11 to 28) 0.56 13 (-6 to 33) 0.21
Social 
functioning
7 (15) 5 (22) 15 (23) 1 (-15 to 18) 0.98 9 (-8 to 26) 0.4 8 (-9 to 24) 0.5
Role – 
emotional
-4 (36) 7 (31) 24 (40) -10 (-41 to 20) 0.69 17 (-14 to 48) 0.4 27 (-2 to 57) 0.08
Mental health -3 (10) 0 (12) 10 (20) -3 (-15 to 9) 0.82 10 (-2 to 22) 0.12 13 (1 to 25) 0.03
Change = last value-first value; a negative change score represents reductions in symptoms; * omitted because of medication use in the conventional treatment arm; 1 0 
(maximal) to 100 (minimal symptoms/medication use) scale, 2 0 (lowest) to-100 (highest level of functioning) scale; 3 after adjustment for multiple comparisonsPage 4 of 5
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